Autophagic Degradation of Gasdermin D Protects against Nucleus Pulposus Cell Pyroptosis and Retards Intervertebral Disc Degeneration In Vivo

Intervertebral disc degeneration (IDD) is the primary culprit of low back pain and renders heavy social burden worldwide. Pyroptosis is a newly discovered form of programmed cell death, which is also involved in nucleus pulposus (NP) cells during IDD progression. Moderate Autophagy activity is critical for NP cell survival, but its relationship with Pyroptosis remains unknown. This study is aimed at investigating the relationship between Autophagy and pyroptotic cell death. The Pyroptosis executor N-terminal domain of gasdermin D (GSDMD-N) and inflammation-related proteins were measured in lipopolysaccharide- (LPS-) treated human NP cells. Inhibition of Autophagy by siRNA transfection and chemical drugs aggravated human NP cell Pyroptosis. Importantly, we found that the autophagy-lysosome pathway and not the Proteasome pathway mediated the degradation of GSDMD-N as lysosome dysfunction promoted the accumulation of cytoplasmic GSDMD-N. Besides, P62/SQSTM1 colocalized with GSDMD-N and mediated its degradation. The administration of the Caspase-1 inhibitor VX-765 could reduce cell Pyroptosis as confirmed in a rat disc IDD model in vivo, whereas ATG5 knockdown significantly accelerated the progression of IDD. In conclusion, our study indicated that Autophagy protects against LPS-induced human NP cell Pyroptosis via a P62/SQSTM1-mediated degradation mechanism and the inhibition of Pyroptosis retards IDD progression in vivo. These findings deepen the understanding of IDD pathogenesis and hold implications in unraveling therapeutic targets for IDD treatment.